June 23 (Reuters) - Forest Laboratories Inc, which is being acquired by generic drugmaker Actavis Plc, said on Monday that its antidepressant Viibryd performed significantly better than a placebo for ...
NEWTON, Mass.--(BUSINESS WIRE)-- Clinical Data, Inc. (NASDAQ: CLDA), today announced that the U.S. Food and Drug Administration (FDA) has approved vilazodone HCl tablets, to be marketed under the ...
VIIBRYD (vilazodone) 10mg, 20mg, 40mg tablets by Clinical Data The FDA has approved Viibryd (vilazodone HCl tablets, from Clinical Data) for the treatment of major depressive disorder (MDD). The FDA ...
The U.S. Food and Drug Administration today approved Viibryd tablets (vilazodone hydrochloride) to treat major depressive disorder in adults. Major depressive disorder, also called major depression, ...
Forest Laboratories, Inc. announced that Viibryd (vilazodone HCl) tablets is now available at pharmacies throughout the United States. Viibryd is a prescription medicine indicated for the treatment of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback